GCA
BSX icon

Greenwood Capital Associates’s Boston Scientific BSX Stock Holding History

Greenwood Capital Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-91,579
Closed -$2.67M – 218
2017
Q3 		$2.67M Buy
91,579
+38,249
+72% +$1.06M 0.66% 70
2017
Q2 		$1.48M Buy
53,330
+564
+1% +$15K 0.38% 80
2017
Q1 		$1.31M Buy
52,766
+5,548
+12% +$135K 0.34% 88
2016
Q4 		$1.02M Sell
47,218
-1,620
-3% -$35.3K 0.29% 86
2016
Q3 		$1.16M Buy
+48,838
New +$1.17M 0.35% 79
2016
Q2 		– Sell
-13,128
Closed -$247K – 175
2016
Q1 		$247K Buy
13,128
+549
+4% +$9.64K 0.08% 144
2015
Q4 		$232K Buy
12,579
+225
+2% +$4.03K 0.07% 142
2015
Q3 		$203K Buy
12,354
+40
+0.3% +$684 0.07% 148
2015
Q2 		$217K Buy
12,314
+90
+0.7% +$1.61K 0.07% 144
2015
Q1 		$216K Buy
+12,224
New +$193K 0.06% 144

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Greenwood Capital Associates's BSX Position: Q4 2017 in Review

Greenwood Capital Associates sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 91,579 shares — an estimated $2.67M sold.

Greenwood Capital Associates first reported a position in BSX in Q1 2015 and held it in 10 quarters. The position peaked at $2.67M in Q3 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Greenwood Capital Associates reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Greenwood Capital Associates sold 91,579 Boston Scientific shares in Q4 2017, an estimated $2.67M.
  • Greenwood Capital Associates first reported a position in Boston Scientific in Q1 2015 and held it in 10 quarters.
  • Greenwood Capital Associates's Boston Scientific position peaked at $2.67M in Q3 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Greenwood Capital Associates's 13F filing for Q4 2017, filed 2 Feb 2018.